The US has exempted Indian pharmaceuticals from tariffs amidst President Trump’s broad tariff imposition, recognizing their ...

The United States is a key market for India’s pharmaceutical exports, with India supplying around 40 per cent of all generic ...

Presently, India imposes 10 percent tariff on Pharma imports from the United States. The US doesn't impose any tariff on ...

Billionaire entrepreneur and Cost Plus Drugs co-founder Mark Cuban won't have to raise medicine prices, as Trump’s new ...

Indian pharmaceutical stocks tumbled 4.4% on Friday, erasing gains from the previous session, after Trump threatened steep ...

India expects minimal price changes for its pharma exports under new US tariffs, as punitive measures haven’t hit the sector ...

Indian pharmaceutical stocks took a hit as Trump's threat of imposing tariffs on pharma imports spooked investors. Despite ...

Of the $91 billion worth of India’s exports to the US, nearly $20 billion are expected to come under some form of exemption ...

Nifty Pharma took a beating on Friday declining over four per cent, after Donald Trump hinted at a separate tariff for ...

Indian shares tumbled after President Donald Trump’s comments that the US is still considering tariffs on pharmaceutical ...

Indian pharmaceutical stocks fell 4.4% on Friday, wiping out gains from the previous session, after U.S. President Donald ...

India emerges stronger in the US-India reciprocal tariffs scenario, negotiating favorable trade agreements and protecting ...